The negative outlook reflects the health system’s revised fiscal year 2017 expectations and its weaker operating performance for the second year.
The ratings agency also affirmed the health system’s “Aa3” and “Aa3/P-1” ratings, affecting $240 million of outstanding revenue bonds.
The affirmation of the “Aa3” rating is based on the health system’s favorable balance sheet metrics, overall size and leading market position. The affirmation of the short-term “Aa3/P-1” rating reflects Moody’s Investors Service’s positive perception of Integris Health’s ability to access the market given its strong revenue bond rating and its frequent participation in the market.
More articles on healthcare finance:
59 hospital outlook and credit rating actions in February
Moody’s affirms ‘VMIG 1’ rating on CHOP’s bonds
S&P revises Peterson Regional Medical Center’s outlook to positive
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
